Bukwang Pharm Co Ltd
KRX:003000
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bukwang Pharm Co Ltd
KRX:003000
|
KR |
|
Krom Bank Indonesia Tbk PT
IDX:BBSI
|
ID |
|
Cosan SA
NYSE:CSAN
|
BR |
|
Eve Health Group Ltd
ASX:EVE
|
AU |
|
S
|
Stanley Agricultural Group Co Ltd
SZSE:002588
|
CN |
|
Yes Bank Ltd
NSE:YESBANK
|
IN |
|
Yangzhou Chenhua New Material Co Ltd
SZSE:300610
|
CN |
|
R Systems International Ltd
NSE:RSYSTEMS
|
IN |
|
Beazley PLC
LSE:BEZ
|
UK |
|
Cherry Hill Mortgage Investment Corp
NYSE:CHMI
|
US |
|
Sempio Co
KRX:007540
|
KR |
|
C
|
Cargotec Corp
OMXH:CGCBV
|
FI |
|
Sears Canada Inc
OTC:SRSCQ
|
CA |
|
M
|
Mingyue Optical Lens Co Ltd
SZSE:301101
|
CN |
|
LG Corp
KRX:003550
|
KR |
|
M
|
Motic Xiamen Electric Group Co Ltd
SZSE:300341
|
CN |
|
Mgi Digital Technology SA
OTC:FRIIF
|
FR |
|
I
|
iZafe Group AB
STO:IZAFE B
|
SE |
|
Navidea Biopharmaceuticals Inc
OTC:NAVB
|
US |
|
American Bank Inc
OTC:AMBK
|
US |
|
Top Shelf International Holdings Ltd
ASX:TSI
|
AU |
|
Danto Holdings Corp
TSE:5337
|
JP |
|
Gemilang International Ltd
HKEX:6163
|
MY |
|
S
|
Shanghai New Vision Microelectronics Co Ltd
SSE:688593
|
CN |
Discount Rate
Cost of Equity
Discount Rate
Bukwang Pharm Co Ltd's Cost of Equity, calculated using the formula
Risk-Free Rate + Beta x ERP,
stands at 7.52%.
The Beta, indicating the stock's volatility relative to the market, is 0.97, while the current Risk-Free Rate, based on government bond yields, is 3.47%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
WACC
Discount Rate
Bukwang Pharm Co Ltd's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax.
The WACC stands at 7.38%. This includes the cost of equity at 7.52%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 5.8%, reflecting the interest rate on
Bukwang Pharm Co Ltd's debt adjusted for tax benefits. The weight of debt in the capital structure is 8.28%.
What is Bukwang Pharm Co Ltd's discount rate?
Bukwang Pharm Co Ltd
's current Cost of Equity is 7.52%, while its WACC stands at 7.38%.
The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."
How is Cost of Equity for Bukwang Pharm Co Ltd calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
Bukwang Pharm Co Ltd
How is WACC for Bukwang Pharm Co Ltd calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
Bukwang Pharm Co Ltd
